Please login to the form below
Ganymed Pharmaceuticals
This page shows the latest Ganymed Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.
Astellas agrees €800m deal to buy Belgian biotech Ogeda
This is the second major deal for Astellas in a few months, following a $1.4bn acquisition of Germany's Ganymed Pharmaceuticals that gave it a gastric cancer antibody (IMAB362) in
Latest news
-
Astellas buys Ganymed to boost immuno-oncology pipeline
Astellas has agreed to pay 422m upfront to buy Ganymed Pharmaceuticals, a German biopharma company specialising in antibody-based cancer drugs. ... If all goes according to plan, Ganymed's shareholders could pick up an additional 860m in milestones,
-
Hexal co-founders continue biotech buy up
The Struengmanns already hold stakes in German biotechnology companies including 4SC and Ganymed Pharmaceuticals, which is developing monoclonal antibody therapeutics to fight solid cancer tumours.
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Featured jobs
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
-
Account Director, Medical Education
-
Salary TBC
- Senior / Principal Medical Writer – Medical Education - UK &...
-
Excellent Salary and Benefits on offer
-
Senior Medical Writer
-
Salary TBC
- Experienced / Senior Medical Writer - MedComms - Cardiff - Wales
-
Excellent Salary and Benefits on offer
- Scientific Director - Medical Education - Cheshire & London ...
-
Excellent Remuneration Package
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
- Senior Medical Writer – Leading Medical Communications Agency – ...
-
Highly Competitive Remuneration Package
- Graduate / Entry Level Opportunities – Medical Communications – ...
-
Highly Competitive Remuneration Package
- Scientific Director - Medical Communications Agency - New York
-
Excellent Remuneration Package
Subscribe to our email news alerts
- Moving annual total (MAT)
- Novartis highlights emerging assets and late-stage pipeline at R&D day
- Seattle Genetics moves to dismiss ADC lawsuit with Daiichi Sankyo
- PMEA 2019 Winners Gallery - PMEA
- UPDATED: BMS completes Celgene merger after FTC okay
- Creativity in storytelling: why pharma must invest more in creativity
- Five key trends in precision and personalised healthcare
- Biogen defends aducanumab filing plan amid scepticism
- UCB’s bimekizumab beats AbbVie’s Humira in phase 3 trial
- Novartis strengthens case for its combination asthma drug
- OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
- Sage slides off a MOUNTAIN as depression drug flunks trial
PMHub
Anthill Agency
Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...
Latest intelligence
- Five key trends in precision and personalised healthcare
- Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
- OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
- Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
- Language barriers: Obesity has become a loaded word
- ...
Quick links
Infographics
